Latest Drug Safety news
FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
posted July 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds
posted June 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Lifts Major Warnings on Hormone Replacement Therapy
posted November 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease Related Articles
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs 
FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements 
FDA Creates "Green List" of GLP-1 Drug Ingredients Approved for Entry in the U.S. 
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA Monthly Specialist Briefings
Stay Connected
